AUERBACH ALAN H
President and CEO
AUERBACH ALAN H has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jul 9, 2026.
On the most recent filing, AUERBACH ALAN H is listed as President and CEO at PUMA BIOTECHNOLOGY, INC. Inside the rolling window, AUERBACH ALAN H reported no open-market purchases and 3 open-market sales totaling $569K in PBYI. The largest disclosed transaction in the window is a sale of 44,058 PBYI shares on Jul 6, 2026, worth $364K.
Companies traded
Other insiders at PBYI
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$569K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has AUERBACH ALAN H made?
AUERBACH ALAN H has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does AUERBACH ALAN H trade?
AUERBACH ALAN H has filed SEC Form 4 disclosures for 1 company, including PBYI.
When was AUERBACH ALAN H's most recent SEC Form 4 filing?
AUERBACH ALAN H's most recent SEC Form 4 filing on Tracefour is dated Jul 9, 2026.
What is AUERBACH ALAN H's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, AUERBACH ALAN H is listed as President and CEO.
What is AUERBACH ALAN H's total buy and sell value in the current window?
Inside the rolling retention window, AUERBACH ALAN H bought $0 and sold $569K based on SEC Form 4 filings.
What was AUERBACH ALAN H's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 44,058 PBYI shares on 2026-07-06, worth $364K, per SEC Form 4 filings.